First FDA-approved fecal-based treatment helps fight C. difficile
Dec 01, 2022
Rebyota is prepared from human stool donated by qualified individuals.
New inflammatory arthritis diagnoses down early in pandemic
Nov 09, 2022
A 20.3% drop was seen in new diagnoses in year commencing April 2020; the median time to first rheumatology assessment decreased.
Tougher federal penalties to come for failing nursing homes
Oct 24, 2022
New penalties will apply to fewer than 0.5 percent of U.S. nursing homes that are already designated as a ‘special focus facility’
NIH investigating COVID-19 experiments conducted at Boston University
Oct 19, 2022
The US National Institutes of Health is investigating COVID-19 experiments at Boston University that have sparked a media firestorm, with some news outlets alleging that scientists created a “killer”...
New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
Specific plasma metabolites linked to cognitive function
Sep 19, 2022
Diet-related metabolites are associated with global cognitive function across studies in adults of various races/ethnicities.
No fewer deaths seen with restricted IV fluid for septic shock
Jun 17, 2022
The rates of death at 90 days, serious adverse events, did not differ for patients with septic shock receiving restricted versus standard IV fluid therapy in the ICU.
Cranberry supplements may aid memory in older adults
May 24, 2022
Improvement in neural functioning also was seen during a 12-week intervention.
Mounjaro approved for blood glucose control in type 2 diabetes
May 20, 2022
The once-weekly injection is approved as an addition to diet and exercise.
U.S. hospitals facing shortage of dye needed for life-saving scans
May 19, 2022
The shortage is expected to last until at least June 30, according to the American Hospital Association.